American Healthcare REIT (AHR) Gains from Sales and Divestitures (2024 - 2026)

American Healthcare REIT has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $24578.0 in Q1 2026.

• For the quarter ending Q1 2026, Gains from Sales and Divestitures changed N/A year-over-year to $24578.0; the trailing twelve-month figure through Mar 2026 stood at $24578.0 (changed N/A YoY), and the FY2025 full-year result was $272967.0, up 86.98% from the prior year.
• Gains from Sales and Divestitures for Q1 2026 stood at $24578.0, down from $272967.0 in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was $272967.0 in Q4 2025, with the low at $24578.0 in Q1 2026.
• Historically, Gains from Sales and Divestitures has averaged $150605.2 across 3 years, with a median of $152438.0 in 2024.
• The largest YoY upside for Gains from Sales and Divestitures was 86.98% in 2025 against a maximum downside of 86.98% in 2025.
• American Healthcare REIT's Gains from Sales and Divestitures stood at $145987.0 in 2024, then jumped by 86.98% to $272967.0 in 2025, then plunged by 91.0% to $24578.0 in 2026.
• The last three Gains from Sales and Divestitures figures came in at $24578.0 (Q1 2026), $272967.0 (Q4 2025), and $158889.0 (Q3 2025), per Business Quant data.